Investigator
Amir Mitchell
UNIV OF MASSACHUSETTS MED SCH WORCESTER · funded by NIAID, NIGMS
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $1.8M
- First award
- Sep 1, 2019
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 10, 2022.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- TEXAS ENGINEERING EXPERIMENT STATION41momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Mechanisms underlying bacterial sensitivity to host-targeted drugs
$923kJun 10, 2022NIAIDUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11089532 (opens the source filing in a new tab)
- R35
Interactions underlying resilient bacterial communities and successful colonization of host niches
$461kSep 1, 2019NIGMSUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11088457 (opens the source filing in a new tab)
- R35
Interactions underlying resilient bacterial communities and successful colonization of host niches
$461kSep 1, 2019NIGMSUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11332741 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources